Pharmacogenetic variability of tuberculosis biomarkers in native and mestizo Peruvian populations
Abstract In Peru, 29 292 people were diagnosed with tuberculosis in 2022. Although tuberculosis treatments are effective, 3.4%–13% are associated with significant adverse drug reactions, with drug‐induced liver injury (DILI) considered the most predominant. Among the first‐line antituberculosis drug...
Spremljeno u:
| Glavni autori: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Wiley
2024-06-01
|
| Serija: | Pharmacology Research & Perspectives |
| Teme: | |
| Online pristup: | https://doi.org/10.1002/prp2.1179 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|